|
CASE REPORT |
|
|
|
Year : 2010 | Volume
: 31
| Issue : 1 | Page : 45-46 |
|
Hidradenitis suppurativa in AIDS
Ravi Khambhati, Priyanka Singhal, YS Marfatia
Department of Skin VD, Government Medical College and SSG Hospital, Vadodara, India
Date of Web Publication | 3-Sep-2010 |
Correspondence Address: Y S Marfatia Professor and Head, Department of Skin VD, Government Medical College and SSG Hospital, Vadodara India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0253-7184.69002
Abstract | | |
Hidradenitis suppurativa (HS) is a disorder of the terminal follicular epithelium in the apocrine gland-bearing skin, characterized by comedo-like follicular occlusion, chronic relapsing inflammation, mucopurulent discharge, and progressive scarring. In this study, we report a case of 35-year-old HIV-positive man with recurrent nodular skin lesions with foul smelling discharge over face, gluteal region, thighs, and axilla. This case is unique because of its association with HIV leading to atypical manifestations and therapeutic challenges.
Keywords: AIDS, Hidradenitis suppurativa, Apocrine gland
How to cite this article: Khambhati R, Singhal P, Marfatia Y S. Hidradenitis suppurativa in AIDS. Indian J Sex Transm Dis 2010;31:45-6 |
How to cite this URL: Khambhati R, Singhal P, Marfatia Y S. Hidradenitis suppurativa in AIDS. Indian J Sex Transm Dis [serial online] 2010 [cited 2023 Sep 21];31:45-6. Available from: https://ijstd.org/text.asp?2010/31/1/45/69002 |
Introduction | |  |
Hidradenitis suppurativa (HS) is a disorder of the terminal follicular epithelium in the apocrine gland-bearing skin. It is characterized by comedo-like follicular occlusion, chronic relapsing inflammation, mucopurulent discharge, and progressive scarring. [1] HIV-induced immunological changes significantly alter the clinical course of chronic skin conditions. Little is known about the association of HIV and HS.
Case Report | |  |
A 35-year-old man is presented with skin lesions over face, thighs, gluteal region, and axilla [Figure 1],[Figure 2],[Figure 3]. As per the patient, he developed nodular skin lesions with foul smelling discharge over face, gluteal region, thighs, and axilla 2 years back. The lesions progressed to form ulcer and scars. The condition responded partially to antibiotic treatment, and the patient suffered from recurrent lesions. He also complained of diarrhea, prolonged fever, and weight loss >10%. Patient had a history of multiple unsafe sexual exposure. There was no history of genital ulcer or discharge.
General examination revealed marked wasting. Inguinal lymphnodes were enlarged, discrete, and nontender. Systemic examination was normal. Multiple nodules, comedons, discharging sinuses, and scarring were present over face, axilla, gluteal region, and posterior thighs. Laboratory investigations: complete blood picture revealed HB 10 g%, total count was low 3000/cumm, differential count showed predominant neutrophils 86/13/1/0, and patient had raised ESR: 70 mm/h. Staphylococcus aureus was isolated in culture. ELISA for HIV was reactive. Due to resource constraints, CD4 count could not be carried out. X-ray and USG abdomen were carried out to study tuberculosis were normal. FNAC of inguinal lymphnodes showed reactive lymphadenitis.
Differential diagnosis considered were HS, Staphylococcal folliculitis, and Eosinophilic folliculitis.
A confirmatory biopsy results showed folliculitis and perifolliculitis with dilated infundibulum containing keratinous material and inflammatory dermis and heavy, mixed inflammatory cell infiltrate consisting of neutrophils, lymphocyte in lower half of dermis suggestive of HS.
Patient was put on oral doxycycline 100 mg BID and ibuprofen. Dapsone 100 mg was added. However, there was partial response with recurrence. Patient had AIDS defining illness, but ART could not be offered as he presented to us in Pre-ART era.
Discussion | |  |
Hidradenitis suppurativa (acne inversa, Pyoderma fistulans significa, and Verneuil's disease) is a chronic suppurating infection that affects the apocrine glands of the axilla, groin, and the perineum. The disease begins with the obstruction of the apocrine gland duct, resulting in the infection of the retained secretions. [2] Following gland obstruction, there is rupture of the gland with spread of infection into the dermis leading to abscess formation and involvement of other apocrine glands. There is the formation of multiple intradermal abscesses, which lead to the development of multiple sinuses, fistulae, and scarring of the skin. Occasionally, the disease extends beyond the dermis into the subcutaneous fat, fascia, and muscle. The lesions present in the form of nodules, discharging sinuses, and comedones predominantly over axillae, anogenital region. [3] Atypical sites were involved in this patient such as face, thighs which could be due to HIV-related immunosuppression. Etiology may also have an endocrinal component, and HIV-associated endocinopathies may alter the course of the disease. Association of AIDS with a chronic skin condition like HS is a therapeutic challenge. Oral retinoids (isotretinoin) have a proven value in unresponsive cases. However, because of financial constraints it could not be used in our patient. Use of isotretinoin for HS in HIV-positive patients on ART needs regular monitoring due to adverse effects such as raised triglycerides and effect on liver transaminases. [4] Other therapeutic options include use of antibiotics such as flucloxacillin or prolonged courses of tetracycline or metronidazole (minimum 3 months) for their anti-inflammatory action. Combination of clindamycin and rifampicin may be effective. Surgical management like incision and drainage of abscesses and excision of scars need to be individualized.
References | |  |
1. | Jovanovic M, Kihiczak G, Robert A, Schwartz. Hidradenitis Suppurativa Available from: http://emedicine.medscape.com/article/1073117-overview. [last accessed on 2010 Jun 23] [last updated on 2010 May 12]. |
2. | Rapini Ronald P, Bolognia JL, Jorizzo Joseph L. Dermatology. Vol. 2 St. Louis: Mosby; 2007. |
3. | Sellheyer K, Krahl D. Hidradenitis suppurativa is acne inversa: An appeal to (finally) abandon a misnomer. Int J Dermatol 2005;44:535-40. [PUBMED] [FULLTEXT] |
4. | Padberg J, Schόrmann D, Grobusch M, Bergmann F. Drug interaction of isotretinoin and protease inhibitors: Support for the cellular retinoic acid-binding protein-1 theory of lipodystrophy. AIDS 1999;13:284-5. |
[Figure 1], [Figure 2], [Figure 3]
This article has been cited by | 1 |
A Comprehensive Review on HIV-Associated Dermatologic Manifestations: From Epidemiology to Clinical Management |
|
| Zeinab Mohseni Afshar, Azadeh Goodarzi, Seyed Naser Emadi, Ronak Miladi, Safoura Shakoei, Alireza Janbakhsh, Zeinab Aryanian, Parvaneh Hatami, Faham Khamesipour | | International Journal of Microbiology. 2023; 2023: 1 | | [Pubmed] | [DOI] | | 2 |
Hidradenitis Suppurativa in Patients with HIV: A Scoping Review |
|
| Laura Macca, Vittoria Moscatt, Manuela Ceccarelli, Ylenia Ingrasciotta, Giuseppe Nunnari, Claudio Guarneri | | Biomedicines. 2022; 10(11): 2761 | | [Pubmed] | [DOI] | | 3 |
Case report of hidradenitis suppurativa localized to the face in an HIV patient |
|
| Brian D Rankin, Richard M Haber | | SAGE Open Medical Case Reports. 2021; 9: 2050313X21 | | [Pubmed] | [DOI] | | 4 |
Hidradenitis suppurativa involving the preauricular region: An unusual location |
|
| Jain, S., Sardana, K., Garg, V.K., Sinha, S. | | Indian Journal of Dermatology, Venereology and Leprology. 2012; 78(2): 229 | | [Pubmed] | | 5 |
Severe hidradenitis suppurative in an HIV-positive male: Use of multiple treatment modalities, including tumor necrosis factor blockade |
|
| Husein-Elahmed, H., Fernandez-Pugnaire, M.-A., Ruiz-Carrascosa, J.-C. | | AIDS Patient Care and STDs. 2011; 25(9): 507-508 | | [Pubmed] | | 6 |
Severe Hidradenitis Suppurative in an HIV-Positive Male: Use of Multiple Treatment Modalities, Including Tumor Necrosis Factor Blockade |
|
| Husein Husein-ElAhmed,Maria-Antonia Fernandez-Pugnaire,Jose-Carlos Ruiz-Carrascosa | | AIDS Patient Care and STDs. 2011; 25(9): 507 | | [Pubmed] | [DOI] | |
|
 |
|
|
|
|